JPH10203996A5 - - Google Patents

Info

Publication number
JPH10203996A5
JPH10203996A5 JP1998005853A JP585398A JPH10203996A5 JP H10203996 A5 JPH10203996 A5 JP H10203996A5 JP 1998005853 A JP1998005853 A JP 1998005853A JP 585398 A JP585398 A JP 585398A JP H10203996 A5 JPH10203996 A5 JP H10203996A5
Authority
JP
Japan
Prior art keywords
composition
casein
energy
tgf
lipid source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998005853A
Other languages
English (en)
Japanese (ja)
Other versions
JPH10203996A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH10203996A publication Critical patent/JPH10203996A/ja
Publication of JPH10203996A5 publication Critical patent/JPH10203996A5/ja
Pending legal-status Critical Current

Links

JP10005853A 1997-01-14 1998-01-14 炎症状態にある胃腸管の治療用組成物とその方法 Pending JPH10203996A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200096 1997-01-14
EP972000962 1997-01-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010024536A Division JP2010100655A (ja) 1997-01-14 2010-02-05 炎症状態にある胃腸管の治療用組成物とその方法

Publications (2)

Publication Number Publication Date
JPH10203996A JPH10203996A (ja) 1998-08-04
JPH10203996A5 true JPH10203996A5 (https=) 2005-08-04

Family

ID=8227929

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10005853A Pending JPH10203996A (ja) 1997-01-14 1998-01-14 炎症状態にある胃腸管の治療用組成物とその方法
JP2010024536A Withdrawn JP2010100655A (ja) 1997-01-14 2010-02-05 炎症状態にある胃腸管の治療用組成物とその方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010024536A Withdrawn JP2010100655A (ja) 1997-01-14 2010-02-05 炎症状態にある胃腸管の治療用組成物とその方法

Country Status (4)

Country Link
US (1) US5952295A (https=)
JP (2) JPH10203996A (https=)
AU (1) AU749365B2 (https=)
CA (1) CA2223198A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034704A1 (en) * 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6210701B1 (en) * 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
EP1372641A4 (en) 2001-03-05 2004-08-25 Stephen P Ernest ENTERAL FORMULATION
CA2444470A1 (en) * 2001-04-10 2002-10-24 Societe Des Produits Nestle S.A. Method and composition for prophylaxis of diabetes
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
JP5204947B2 (ja) 2002-11-27 2013-06-05 ディーエムアイ バイオサイエンシズ インコーポレイテッド リン酸受容体化合物の使用、ならびにリン酸受容体化合物を含んでいる、薬学的組成物、スキンケア用の組成物、およびキット
TR201907898T4 (tr) * 2003-01-31 2019-06-21 Dsm Ip Assets Bv Karotenoidler içeren yeni bileşimler.
CA2518552A1 (en) * 2003-03-11 2004-09-23 Genentech, Inc. Novel compositions and methods for the treatment of immune related disease
US7875291B1 (en) 2003-09-05 2011-01-25 Glu-Pro, Inc. Composition for managing diabetes, obesity, and hyperlipidemia and associated methods
WO2005039318A1 (en) * 2003-10-16 2005-05-06 Nestec S.A. Nutritional composition against side effects of chemotherapy of radiotherapy
US7763257B2 (en) * 2004-12-09 2010-07-27 Christina Juneau Compositions comprising transforming growth factor (TGF)-β1 and TGF-β2 in admixture of proteins obtained from dairy products
US20060127493A1 (en) * 2004-12-09 2006-06-15 Yves Pouliot Composition for treating psoriasis
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8287931B2 (en) * 2005-06-30 2012-10-16 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
DK1800675T3 (da) * 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens
US20090186034A1 (en) * 2006-12-19 2009-07-23 Genetech, Inc. Gene expression markers for inflammatory bowel disease
EP2261367A3 (en) 2007-11-29 2011-03-23 Genentech, Inc. Gene expression markers for inflammatory bowel disease
US8986769B2 (en) * 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8367354B2 (en) * 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8350006B2 (en) * 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
US8293264B2 (en) * 2009-05-11 2012-10-23 Mead Johnson Nutrition Company Nutritional composition to promote healthy development and growth
CN102639710A (zh) 2009-07-20 2012-08-15 基因泰克公司 克罗恩病的基因表达标记
EP2311486A1 (en) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 for use in intestine and muscle recovery
WO2012071436A1 (en) 2010-11-24 2012-05-31 Genentech, Inc. Method of treating autoimmune inflammatory disorders using il-23r loss-of-function mutants
US20120171328A1 (en) * 2011-01-05 2012-07-05 Dattatreya Banavara Composition comprising heat labile milk proteins and process for preparing same
US20210176999A1 (en) 2011-04-17 2021-06-17 Omega Foods, LLC Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids
JP6368306B2 (ja) * 2012-07-31 2018-08-01 ネステク ソシエテ アノニム 炎症性腸疾患（ｉｂｄ）患者の筋骨格の健康を促進させるための栄養組成物
PL3212198T3 (pl) 2014-10-29 2021-08-23 Glycom A/S Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
IT201900008394A1 (it) * 2019-06-07 2020-12-07 Sofar Spa Composizione per uso nel trattamento delle malattie infiammatorie croniche intestinali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60203172A (ja) * 1984-03-29 1985-10-14 Sanwa Kagaku Kenkyusho:Kk 経口・経管栄養食
GB8723094D0 (en) * 1987-10-01 1987-11-04 Ciba Geigy Ag Polypeptide growth factor from milk
JP3102645B2 (ja) * 1990-10-15 2000-10-23 雪印乳業株式会社 栄養補給用栄養組成物
EP0527283B1 (en) * 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Food composition
US5661123A (en) * 1995-01-17 1997-08-26 Nestec, Ltd. Enteral composition for malabsorbing patients

Similar Documents

Publication Publication Date Title
JPH10203996A5 (https=)
RU2008130365A (ru) Питательные композиции для младенцев, предназначенные для предупреждения ожирения
CA1261274A (en) Pharmaceutical and dietary compositions
CN1091363C (zh) 脂肪掺合物
AU727637B2 (en) Nutritional support of paediatric patients
CN101360490A (zh) 具有二十二碳五烯酸的组合物
CN1099610A (zh) 用于吸烟者的制剂
JP2009521214A5 (https=)
CA2362271A1 (en) Essential fatty acids in the prevention of cardiovascular events
DE69935995D1 (de) Polyungesättigen fettsäuren nährungsergänzung
WO2005025334A1 (en) Lipid system and methods of use
PT1216041E (pt) Dieta com elevado teor de lipidos
JPH08193028A (ja) ヘリコバクターの阻害
CS545686A1 (en) Farmaceuticky prostredek a antihepatotoxickym pusobenim
CA2039980A1 (en) Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients
ZA971134B (en) Multifunctional fat absorption and blood cholesterol reducing formulation.
AU2441400A (en) Stabilized lipidic composition, method for the preparation thereof and nutritional product containing the same
ATE56148T1 (de) Orales dextran enthaltende zusammensetzungen.
JP3102645B2 (ja) 栄養補給用栄養組成物
Das Hypothesis: cis-unsaturated fatty acids as potential anti-peptic ulcer drugs
CA1279823C (en) Pharmaceutical and dietary composition for pre-menstrual syndrome
Tsujikawa et al. Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis
Jensen et al. Effect of hypophysectomy on lipid composition in the immature rat
Matsuba et al. Effect of dietary linoleate/α-linolenate balance on experimentally induced gastric injury in rats
Wang et al. The duration of medium-chain triglyceride feeding determines brush border membrane lipid composition and hydrolase activity in newly weaned rats